Did Pfizer "spread" heart damage signals into other PTs to report fewer myocarditis cases?

An investigation of four fatal foreign VAERS reports

Summary:

• In their Summary Monthly Safety Report (SMSR) for the month ending September 2021, Pfizer reported 4 deaths in the 12-15 cohort

• Pfizer mentioned that there were no deaths due to Myocarditis and Pericarditis in the 12-15 cohort during that time period, clearly implying that those 4 deaths were due to other conditions

• Based on the information provided, I was able to locate the 4 corresponding VAERS reports in the foreign dataset

• It is quite easy to locate other VAERS reports where the patient was diagnosed with Myocarditis and suffered from the same symptoms. This means the 4 reported cases have symptoms which could also be explained by Myocarditis, but were not coded with Myocarditis in the preferred terms (PTs) which show up in the SYMPTOMS file.

• In turn, this means these 4 reports will not show up if someone searched CDC WONDER for deaths from Myocarditis for the 12-15 age cohort for that time period

• On top of that, the followup of the autopsy reports for these 4 deaths has not been provided in the FOIA response¹, so we don’t yet know if Myocarditis has been ruled out as the cause for all of them

This is a followup to my series on the Pfizer pharmaco-vigilance plan (PVP) report.

I got this comment from

Geoff Pain PhD

on my previous article:

Pfizer spread its early Process 2 jab Heart damage signals under 36 different "carditis" headings. To June 2022 (PSUR3) this amounted to 22,508 "carditis" victims known to the company. Pfizer used 243 different terms for "Cardiac Disorder" Adverse Events.

Link

I think I might have found an example of this in the Summary Monthly Safety Report (SMSR) for September 2021²

Pfizer monitored adverse events within two “topics” (among many others):

• 12-15 age group

• myocarditis and pericarditis

Four fatal VAERS reports

There were four fatal VAERS reports in the 12-15 cohort, and this is how they were reported

Source: Page 95 of the September 2021 SMSR

Warning: The link above goes to a 100MB+ file, so it may not open directly in your browser. It would be better to download the file and then navigate to the page.

However, a few pages later, they report the following in the myocarditis and pericarditis topic for the same age cohort:

Notice that they say “None of the cases in this age group had a fatal outcome”

Just in case you might wonder if this phrase was a one-off and maybe a mistake, do note that I searched for that exact same phrase and also found it in the document called “Signal assessment report on Myocarditis, pericarditis with Tozinameran (COVID-19 mRNA vaccine (nucleoside- modified) – COMIRNATY)“ by the European Medicines Agency (EMA) dated 2nd December 2021

You can see the same phrase on page 30 of the EMA document.

Source: Page 30 of the EMA report

So it is fair to say that there were at least two health regulators who got this information from Pfizer³.

There are two things to note about each fatal case reported in the SMSR document:

• they describe symptoms which could be caused by Myocarditis

• they do not provide autopsy results proving otherwise

Here is an example where the assessment for Myocarditis was negative⁴. (emphasis mine)

Electroencephalography results pending + Left transcranial doppler more disturbed than the right (Vdiastolic 20 vs 40 on the right), Control contrast enhanced computed tomography scan superimposable at the level of large vsx, but appearance of parenchymal parenchymal hemispherical hemispherical right upper cerebellar areas of ischemic appearance. 20Jul2021 pathological awakening, inhalation lung disease, myocarditis assessment in progress (negative). 23Jul2021 no sign of wakign up flat electroencephalogram alternating with a few waves of intermittent activity.

Link

It is possible to use the information provided in the SMSR document by Pfizer and identify the VAERS report⁵ and I have listed them below.

15 | M | Jordan

Description in the SMSR:

One case from Jordan described a 15-year-old male patient who received the 1st vaccine dose on 09 August 2021 and died on 13 August due to respiratory and circulatory failure. It was not reported if an autopsy was performed. The investigations performed on the impacted lot (FF2154) did not identify any quality issue.

The corresponding VAERS report was received on 3rd Sep 2021, and published on 10th Sep 2021. You can read the report here.

Here is the question we want answered:

Can Myocarditis cause respiratory failure, or occur because of it⁶?

This is fairly easy to search with my search demo for serious foreign VAERS reports.

I first filter for Myocarditis in the symptom, then search for the phrase “respiratory failure”

Here is an example report (emphasis mine) for a 11 year old girl from Japan

cardiac failure acute which was acute myocarditis-like; Cardio-respiratory arrest; from the evening of 30Apr2022, respiratory failure was noted; Bradycardia; cyanosis / systemic cyanosis; Gradually the pulse was decreased; Blood pressure decreased; blood pressure could no longer be measured / blood pressure became unmeasurable; Tachycardia / heart rate was 130-150/min; Cold sweat; Fatigue; Malaise developed 22 hours after the vaccination; cardiac failure acute which was acute myocarditis-like / Suspected acute myocarditis; Energy decreased; Palpitations; Sweaty;

Link

In case you are wondering, this death happened only in 2022 and so wasn’t included in any safety reports submitted to the FDA by Oct 2021.

I am trying to provide examples of Myocarditis occuring alongside the symptom mentioned in the SMSR document.

15 | M | Spain

Here is the next case:

One case from Spain involved a 15-year-old male patient who received the vaccine (dose number unspecified) and experienced Cardiorespiratory arrest and died (PT: Sudden death) 7 days after vaccine administration.

The corresponding VAERS report was received on 15th Sep 2021, and published on 17th Sep 2021. You can read the report here.

Here is an example of myocarditis occuring alongside cardiorespiratory arrest⁷:

The following information was reported: MYOCARDITIS (death, hospitalization, medically significant), CARDIO-RESPIRATORY ARREST (death, hospitalization, medically significant) all with onset 15Jan2022, outcome "fatal" and all described as "Cardiac arrest, eventual myocarditis"; COVID-19 (death, hospitalization) with onset 15Jan2022, outcome "fatal", described as "sars-cov-2 test: (15Jan2022) positive;".

Link

14 | M | Spain

Here is the description for the next case:

One case from Spain involved a 14-year-old male patient who received the 2nd vaccine dose on 27 July 2021 and died on 3 September 2021. Pulmonary oedema was the cause of death reported in the autopsy.

The corresponding VAERS report was received on 10th Sep 2021, and published on 17th Sep 2021. You can read the report here.

Here is an example of pulmonary oedema (emphasis mine)

breathing difficulty; chest pain; Hepatic function disorder; convulsion; oxygen saturation (SpO2) was decreased at 86%; cyanosis; pupils dilated; pupillary light reflex lost; pulmonary oedema; ventricular hypokinesia; brain disorder; hypoxic encephalopathy; Tako-Tsubo cardiomyopathy; cardiomyopathy; mass in the left adrenal gland; brain function would be poor; sepsis and myocarditis due to severe infection occurred in combination causing severe disease; sepsis and myocarditis due to severe infection occurred in combination causing severe disease; sepsis and myocarditis due to severe infection occurred in combination causing severe disease;

Link

Since the report was from Japan, they actually make a honest effort to provide a detailed summary later on in the same report (emphasis mine):

Other possible cause of the events was reported as follows: Anaphylaxis was not actively suspected because the symptoms such as urticaria, redness or mucosal symptoms were not observed. Pulmonary embolism was deniable from the result of the contrast enhanced CT. Regarding myocarditis, CK-MB 126.9 U/L was noted indicating relatively low increase considering the patient''s symptom. Obvious cause was unknown, but it was assumed that sepsis and myocarditis due to severe infection occurred in combination causing severe disease. The reporting physician commented as follows: There was no information on his history of the vaccine at the time of visiting, but there were no marked findings suggestive of anaphylaxis, thromboembolism or myocarditis. However, as autopsy was not performed, obvious cause was uncertain, and there were no diseases which could be considered as an explicable cause of the events. Therefore, the causal relationship with the vaccination could not be ruled out. The patient died on 05Oct2021 due to convulsion, hepatic function disorder, sepsis, myocarditis, and severe infection. Autopsy was not performed. Outcome of the other events was unknown.;

I wish we got similarly detailed assessments from the other countries.

15 | M | Greece

Here is the next case:

One case from Greece involved a 15-year-old male patient who received the 1st vaccine dose and 3 days later died (Sudden death). The autopsy was performed and the results were not available at the time of the report.

The corresponding VAERS report was received on 25th Sep 2021, and published on 1st Oct 2021. You can read the report here.

This is a case of sudden death, and somehow the vaccine pushers have a very hard time locating such reports in VAERS even though they are quite easy to find.

You can read the article above and find many examples of sudden death reports.

In case you don’t want to read an entire article, here is another example from Japan (emphasis mine):

The course of the event was as follows: On 31Oct2021 (the day of vaccination), the patient experienced pyrexia with a temperature of the level of 37 degrees Centigrade. On 03Nov2021(3 days after the vaccination), the outcome of the event was fatal. Pyrexia persisted afterwards. On 03Nov2021, 3 days after the vaccination, he experienced sudden death. The reporting physician classified the event as serious(death), and assessed that the event was related to BNT162b2. There was no other possible cause of the event such as any other diseases.

Link

The description of the myocarditis investigation was also very detailed in the above report, and I wonder if other countries did as thorough an investigation when they tried to rule out other causes:

Myocarditis Investigation Form: On 08Mar2022(4 months 8 days after the vaccination), the patient received autopsy, details of inflammatory findings of myocardial tissue were Macrophage and T-lymphocyte infiltrated into the myocardium of the left ventricle broadly and into part of the myocardium of the right ventricle. On 05Nov2021(5 days after the vaccination), the patient received C-reactive protein(CRP), the C-reactive protein Elevated and was 1.2mg/dl. No other test(s) that should be specially noted. Other disease(s) accountable for clinical symptom(s)/findings are ruled out. Cardiac MRI examination, Cardiac ultrasonography or Electrocardiography were not performed. The reporting physician commented as follows: A autopsy examination revealed C-reactive protein (CRP) increased, and a pathological examination showed a wide range of inflammatory cell infiltrate in the cardiac muscle. Based on the results, myocarditis was diagnosed. No other injuries, lesions, poisonings, or allergies were found. No appreciable family history or past history was noted. The patient experienced pyrexia and physical deconditioning, which persisted after the vaccination, and died on the 3rd day. In addition, lesions other than myocarditis could not be found. The reporter therefore suspect the causality with the vaccination and report this case. This report met the criteria of myocarditis.

Conclusion

Obviously, there isn’t any way for me to conclusively say that Pfizer was trying to spread the heart damage signals into preferred terms (PTs) different from Myocarditis just to reduce the number of such reports.

But I DO find it quite suspicious that the final SMSR report (September 2021) coincided with the booster approval, and also concluded Pfizer’s FOIA response obligations⁸.

Link to tweet

In other words, there is no October 2021 SMSR which we can go and read so we can find out if Pfizer ever bothered to do a follow up, so as to procure and publish the autopsy results for those four fatal cases.

1. I don’t know if this is because there were no more Summary Monthly Safety Reports (SMSR) after Sep 2021 as it was the last one, or if the FOIA did not require Pfizer to submit the later SMSRs

2. These monthly safety reports were then compiled into the PVP report. At least, that is my understanding till date.

3. Interestingly, the September 2021 is the last SMSR which was provided by Pfizer in the FOIA response. So we don’t know if they would have used the same verbiage for the next month, although I think it would have been impossible given that by then there was already at least one such fatal report.

4. I am adding this report as an example to show that it was possible to make assessments and declare that a death was not due to myocarditis. In addition, as you can infer from this article, I also think Pfizer had an incentive to do such an assessment whenever possible.

5. This mapping would not have been possible without reading the text writeup. Once again, I would like to remind the readers that the CDC decided to unpublish the text writeup for EU VAERS reports. Three of the four reports investigated here were from the EU region.

6. As I have mentioned before, I don’t have a background in medicine or biology. I look for both these answers because sometimes Myocarditis causes the other condition, but in some cases the other condition causes Myocarditis

7. The report in fact says that the cardiorespiratory arrest caused the myocarditis.

8. At least that is my understanding from reading the cited tweet